| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | BUY | 10,688 @ EUR 10.29 | EUR 109,980 | The ETF bought 10688 new shares of GRF.MC (Grifols SA). The shares were bought for an average price of 10.29 compared to the previous average buy price of 10.08. This is 2.1% higher than average price of previous purchases of GRF.MC. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 120.5 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 120.5. The average price that BIM.PA shares were previous bought at was EUR 110.633. The current market price is 8.9% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 36,269 (USD $41,427) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 305.283 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 305.283. The average price that RO.SW shares were previous bought at was CHF 302.302. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 5,342 (USD $6,531) compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 50.52 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 50.52. The average price that FME.DE shares were previous bought at was EUR 46.8565. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 61,029 (USD $69,708) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 56.96 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 56.96. The average price that ERF.PA shares were previous bought at was EUR 51.0554. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 23,457 (USD $26,793) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 206.1 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 206.1. The average price that SRT3.DE shares were previous bought at was EUR 220.626. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 19,672 (USD $22,469) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 28.0611 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 28.0611. The average price that SOBI.ST shares were previous bought at was SEK 26.9812. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 20,430 (USD $2,133) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 120.601 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 120.601. The average price that GALD.SW shares were previous bought at was CHF 104.269. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 16,519 (USD $20,195) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 193.85 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 193.85. The average price that DIM.PA shares were previous bought at was EUR 190.197. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 1,729 (USD $1,975) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 52.95 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 52.95. The average price that REC.MI shares were previous bought at was EUR 52.548. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 15,858 (USD $18,113) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 62.35 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 62.35. The average price that ORNBV.HE shares were previous bought at was EUR 50.7131. The current market price is 22.9% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 36,460 (USD $41,645) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 13.2514 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 13.2514. The average price that SN.L shares were previous bought at was GBP 12.775. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 130,774 (USD $177,227) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 104.1 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 104.1. The average price that IPN.PA shares were previous bought at was EUR 107.092. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 5,935 (USD $6,779) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 24.9606 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.9606. The average price that HIK.L shares were previous bought at was GBP 24.4976. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 1,511 (USD $2,048) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 34.1556 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 34.1556. The average price that DEMANT.CO shares were previous bought at was DKK 34.1992. The current market price is -0.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 29 (USD $4) compared to the previous valuation of |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 91.06 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 91.06. The average price that DIA.MI shares were previous bought at was EUR 68.5775. The current market price is 32.8% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 1,078 (USD $1,231) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 63.901 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 63.901. The average price that NOVO-B.CO shares were previous bought at was DKK 65.9517. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 2,089 (USD $320) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 84.263 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 84.263. The average price that COLO-B.CO shares were previous bought at was DKK 92.5737. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 108 (USD $17) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 37.615 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 37.615. The average price that QIA.DE shares were previous bought at was EUR 37.624. The current market price is 0.0% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 231,653 (USD $264,595) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.78451 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.78451. The average price that HLN.L shares were previous bought at was GBP 4.70903. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 165,581 (USD $224,398) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 26.43 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 26.43. The average price that BAYN.DE shares were previous bought at was EUR 21.9962. The current market price is 20.2% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 432,031 (USD $493,468) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 102.9 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 102.9. The average price that NOVN.SW shares were previous bought at was CHF 98.158. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 183,160 (USD $223,920) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 126.938 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 126.938. The average price that AZN.L shares were previous bought at was GBP 128.315. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 558,941 (USD $757,486) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 87.49 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 87.49. The average price that SAN.PA shares were previous bought at was EUR 95.2663. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 162,742 (USD $185,885) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.9375 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.9375. The average price that GSK.L shares were previous bought at was GBP 16.7885. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 319,533 (USD $433,036) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 245.5 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 245.5. The average price that EL.PA shares were previous bought at was EUR 248.822. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 188,514 (USD $215,322) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 597.792 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 597.792. The average price that LONN.SW shares were previous bought at was CHF 584.866. The current market price is 2.2% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 83,743 (USD $102,379) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 76.3845 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 76.3845. The average price that ALC.SW shares were previous bought at was CHF 81.3862. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 241,494 (USD $295,236) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 510.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 510.8. The average price that ARGX.BR shares were previous bought at was EUR 551.897. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 67,749 (USD $77,383) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 162.7 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 162.7. The average price that UCB.BR shares were previous bought at was EUR 171.449. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 62,614 (USD $71,518) compared to the previous valuation of UCB SA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 284.952 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 284.952. The average price that ROG.SW shares were previous bought at was CHF 285.605. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 182,859 (USD $223,552) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 20.37 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 20.37. The average price that PHIA.AS shares were previous bought at was EUR 23.2154. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 59,397 (USD $67,844) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 115.4 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 115.4. The average price that MRK.DE shares were previous bought at was EUR 130.164. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 46,080 (USD $52,633) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 46.612 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 46.612. The average price that SDZ.SW shares were previous bought at was CHF 40.3939. The current market price is 15.4% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 204,917 (USD $250,519) compared to the previous valuation of however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 270.582 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 270.582. The average price that SOON.SW shares were previous bought at was CHF 291.912. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 24,857 (USD $30,389) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.53 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.53. The average price that SHL.DE shares were previous bought at was EUR 48.2129. The current market price is -3.5% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 56,311 (USD $64,319) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 44.24 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 44.24. The average price that FRE.DE shares were previous bought at was EUR 37.9992. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 63,595 (USD $72,638) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-06-05 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 192.829 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 192.829. The average price that GMAB.CO shares were previous bought at was DKK 190.425. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 125 (USD $19) compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 113.204 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 113.204. The average price that STMN.SW shares were previous bought at was CHF 118.249. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 28,022 (USD $34,258) compared to the previous valuation of |